IDEXX Laboratories Guides FY26 In Line With Estimates - Update

Core Viewpoint - IDEXX Laboratories, Inc. has provided its earnings and revenue guidance for the full-year 2026, aligning with analysts' expectations [1][2]. Financial Projections - For fiscal 2026, IDEXX projects earnings per share between $14.29 and $14.80, with revenues expected to be between $4.632 billion and $4.720 billion, indicating a revenue growth of 7.6 to 9.6 percent and organic revenue growth of 7 to 9 percent [1]. - Analysts' average expectations for the company are earnings of $14.45 per share and revenues of $4.66 billion for the year, typically excluding special items [2]. Market Performance - In pre-market trading on Nasdaq, IDEXX shares are priced at $669.95, reflecting a decrease of $0.51 or 0.08 percent [2].